Cormark Brokers Decrease Earnings Estimates for Curaleaf

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Cormark dropped their FY2025 earnings per share (EPS) estimates for Curaleaf in a research report issued to clients and investors on Wednesday, April 30th. Cormark analyst J. Pytlak now expects that the company will earn ($0.25) per share for the year, down from their previous forecast of ($0.23). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share.

Curaleaf (OTCMKTS:CURLF) last released its earnings results on Monday, March 3rd. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.09. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%. The firm had revenue of $331.05 million for the quarter, compared to the consensus estimate of $331.87 million.

Curaleaf Price Performance

Shares of CURLF opened at $0.96 on Friday. The firm’s 50-day simple moving average is $0.94 and its two-hundred day simple moving average is $1.55. Curaleaf has a fifty-two week low of $0.68 and a fifty-two week high of $6.10. The stock has a market cap of $636.06 million, a PE ratio of -3.31 and a beta of 0.95. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 1.11.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.